Cell free DNA as a diagnostic and prognostic marker for cardiovascular diseases
- 21 January 2020
- journal article
- review article
- Published by Elsevier BV in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 503, 145-150
- https://doi.org/10.1016/j.cca.2020.01.013
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- American Physiological Society
This publication has 77 references indexed in Scilit:
- Oxidized Extracellular DNA as a Stress Signal in Human CellsOxidative Medicine and Cellular Longevity, 2013
- Circulating Cell-Free DNASports Medicine, 2012
- Mitochondrial DNA that escapes from autophagy causes inflammation and heart failureNature, 2012
- Inflammation, Immunity, and HypertensionHypertension, 2011
- Mapping Tissue-Specific Expression of Extracellular Proteins Using Systematic Glycoproteomic Analysis of Different Mouse TissuesJournal of Proteome Research, 2010
- The utility of troponin measurement to detect myocardial infarction: review of the current findingsVascular Health and Risk Management, 2010
- Levels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumorsMolecular Cancer, 2009
- Plasma matrix metalloproteinase-9 and left ventricular remodelling after acute myocardial infarction in man: a prospective cohort studyEuropean Heart Journal, 2007
- IL-6 levels in acute and post myocardial infarction: their relation to CRP levels, infarction size, left ventricular systolic function, and heart failureEuropean Journal of Internal Medicine, 2004
- HMG-CoA Reductase Inhibitors Improve Endothelial Dysfunction in Normocholesterolemic Hypertension via Reduced Production of Reactive Oxygen SpeciesHypertension, 2001